MedTrace Logo

Electronic Early Notification of Sepsis in Hospitalized Ward Patients

NCT04078594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65250

Last updated 2023-03-14

No results posted yet for this study

Summary

Screening for sepsis has been recommended by the Surviving Sepsis Campaign Clinical Practice Guidelines to facilitate early identification and early management of sepsis. However, the optimal tool remains unknown.The objective of this trial is to examine the effect of an electronic sepsis alert tool on reducing hospital mortailty in patients admitted to medical-surgical-oncology wards.

Conditions

Interventions

OTHER

sepsis e-alert

At 2-each month interval, the e-alert will be activated in five new randomly selected wards, until all wards eventually will have active alert

Sponsors & Collaborators

  • King Abdulaziz Medical City, Jeddah

    collaborator UNKNOWN

  • Prince Mohammed Bin Abdul Aziz Hospital - AlMadinah

    collaborator UNKNOWN

  • King Abdulaziz Hospital, Al Ahsa

    collaborator UNKNOWN

  • Imam Abdulrahman Al Faisal Hospital - Dammam

    collaborator UNKNOWN

  • King Abdullah International Medical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-08-30
Completion
2022-11-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04078594 on ClinicalTrials.gov